RT Journal Article
SR Electronic
T1 NSTEMI Decide: Development of a Decision Aid for Older Adults with Non ST Elevation Myocardial Infarction
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.29.21261343
DO 10.1101/2021.07.29.21261343
A1 Summapund, Jenny
A1 Sibley, Rachel A.
A1 Iqbal, Sohah
A1 Kiefer, Nicholas J.
A1 Langford, Aisha
A1 Spatz, Erica
A1 Barnett, Mallory
A1 Rivers, Joshua
A1 Chaudhry, Sarwat I.
A1 Dickson, Victoria V.
A1 Sikand, Nikhil V.
A1 Matlock, Daniel D.
A1 Dodson, John A.
YR 2021
UL http://medrxiv.org/content/early/2021/07/31/2021.07.29.21261343.abstract
AB Background Many patients hospitalized with non-ST elevation myocardial infarction (NSTEMI) are older adults (age ≥75), in whom invasive coronary angiography confers potential benefits but also higher risks than the general population. Our goal was to therefore develop a patient decision aid (PtDA) to assist with shared decision making (SDM) between cardiologists and older adults with this condition.Methods We followed International Patient Decision Aid Standards to develop the NSTEMI Decide PtDA. The initial prototype was based on structured interviews from 20 patients and 20 clinicians. Risks and benefits of invasive coronary angiography were derived from the available literature in older adults, with an emphasis on findings from randomized trials. The PtDA was then revised through an iterative, user-centered design approach with rapid prototyping using input from both clinician and patients to meet the needs of both stakeholders.Results The PtDA went through 8 iterations. The final decision aid was 11 pages and included background information (6 pages), explanation of benefits and risks (4 pages), and a summary (1 page). Large font (≥26 point) was used to accommodate visual difficulties. Language was tailored to an 8th grade reading level. Based on the best available literature, we included benefits of invasive coronary angiography (recurrent myocardial infarction, repeat revascularization) and risks (stroke, bleeding, acute kidney injury). The final PtDA was converted to a mobile health application to increase usability on portable digital devices in the clinical setting.Conclusions We developed the first PtDA tailored to older adults hospitalized with NSTEMI. This PtDA will be prospectively tested to evaluate dimensions including feasibility of use, satisfaction with care, medical knowledge, and decisional conflict.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by a Patient-Oriented Career Development Award K23 (AG052463) from the NIH/NIA. All authors have no conflicts of interests to disclose.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All aspects of the study were approved by the NYU Grossman School of Medicine Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the supplementary materials. Additional data that support the findings of this study are available on request from the corresponding author, JAD.